http://www.appliedradiology.com RSS Feed on Applied Radiologyhttp://www.appliedradiology.com//Issues/2001/08/Supplements/Gadolinium-based-MR-Contrast-Safety-Issues--The-UPMC-Experience.aspxTo date, four gadolinium-based magnetic resonance (MR) imaging contrast agents have been approved by the Food and Drug Administration for use in the United States: Magnevist® (gadopentetate dimeglumine), ProHance® (gadoteridol), Omniscan® (gadodiamide), and OptiMARK® (gadoversetamide). Al-though there are many similarities among these agents, there are also some differences. Clinicians need to review the literature and decide for themselves if these differences and similarities are in fact clinically significant in any one particular area or adverse event, focusing on attributes that are important to their practice. This presentation will briefly review the safety data for these four agents and then will present our experience at the University of Pittsburgh Medical Center (UPMC) with all of the agents, focusing on our decision-making process and the research we conducted in choosing a gadolium-based MR contrast agent.Thursday, 17 Jan 2002 00:19:09 GMT